Related Experiment Video
Updated: Sep 1, 2025

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
The path via pathway-based approaches towards safety assessment: A concise review
Yuan Jin1, Guangshuai Qi1, Meiyao Feng2
1School of Public Health, Qingdao University, Qingdao, China.
This review highlights the progress in pathway-based chemical safety assessment, moving from animal testing to in vitro methods and computational systems biology. It discusses challenges and future directions for mechanism-driven safety evaluations.
Area of Science:
- Toxicology
- Computational Biology
- Regulatory Science
Background:
- The need to replace animal testing in chemical safety assessment has driven the development of alternative methods.
- Integrated Testing Strategies (ITS) in Europe and the in vitro toxicity testing paradigm in the US (since 2007) represent key shifts.
- The Adverse Outcome Pathway (AOP) framework, introduced in 2010, advanced pathway-based approaches in regulatory toxicology.
Purpose of the Study:
- To review achievements in pathway-based chemical assessment since 2007.
- To discuss potential pitfalls and challenges in mechanism-driven chemical assessment.
- To present future perspectives on safety assessment utilizing computational systems biology.
Main Methods:
- Review of scientific literature and regulatory initiatives.
- Analysis of advancements in computational modeling, high-throughput screening, and high-content omics.
- Discussion of conceptual frameworks like AOPs.
Main Results:
- Significant progress has been made in developing pathway-based chemical assessment frameworks.
- Computational modeling and omics technologies are crucial for facilitating these advancements.
- The field is moving towards a more mechanism-driven approach to chemical safety.
Conclusions:
- Pathway-based chemical assessment, integrating various data sources and advanced technologies, is the future of toxicology.
- Overcoming challenges in mechanism-driven assessment is key to realizing a paradigm shift.
- Computational systems biology offers promising avenues for future safety evaluations.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Preclinical Development: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Criteria for Causality: Bradford Hill Criteria - II
Mutagenicity and Carcinogenicity

